Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.gov public full text Public Domain

GH21 Combined With D-1553 in KRAS G12C Mutant Advanced Solid Tumors

Suzhou Genhouse Bio Co., Ltd. · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
This s a multi-center, open-label phase Ib/II study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of GH21 combined with D-1553 in patients with advanced or metastatic solid tumors harboring KRAS G12C mutation.
Conceptio Open Archive

Analyze & explore related research in Conceptio

Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.

This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1094222
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive